Harrow Inc (HROW)
43.88
+1.44
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.30
(-0.68%)
After-Hours: 20:00
Harrow Shareholders Equity (Quarterly): 57.98M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 57.98M |
June 30, 2024 | 58.53M |
March 31, 2024 | 60.56M |
December 31, 2023 | 70.77M |
September 30, 2023 | 75.76M |
June 30, 2023 | 22.41M |
March 31, 2023 | 21.88M |
December 31, 2022 | 27.60M |
September 30, 2022 | 1.217M |
June 30, 2022 | 5.749M |
March 31, 2022 | 10.09M |
December 31, 2021 | 11.29M |
September 30, 2021 | 16.59M |
June 30, 2021 | 23.20M |
March 31, 2021 | 28.22M |
December 31, 2020 | 27.18M |
September 30, 2020 | 25.28M |
June 30, 2020 | 15.73M |
March 31, 2020 | 15.34M |
December 31, 2019 | 27.71M |
September 30, 2019 | 23.96M |
June 30, 2019 | 35.06M |
March 31, 2019 | 37.06M |
December 31, 2018 | 24.75M |
September 30, 2018 | 4.453M |
Date | Value |
---|---|
June 30, 2018 | 3.732M |
March 31, 2018 | 0.083M |
December 31, 2017 | 2.615M |
September 30, 2017 | 3.746M |
June 30, 2017 | 7.646M |
March 31, 2017 | 5.317M |
December 31, 2016 | 6.432M |
September 30, 2016 | 2.832M |
June 30, 2016 | 5.608M |
March 31, 2016 | 8.784M |
December 31, 2015 | -1.385M |
September 30, 2015 | 2.244M |
June 30, 2015 | 5.24M |
March 31, 2015 | 6.206M |
December 31, 2014 | 8.15M |
September 30, 2014 | 10.28M |
June 30, 2014 | 12.04M |
March 31, 2014 | 13.80M |
December 31, 2013 | 15.11M |
September 30, 2013 | 16.34M |
June 30, 2013 | 17.27M |
March 31, 2013 | 18.40M |
December 31, 2012 | 9.996M |
September 30, 2012 | 10.79M |
June 30, 2012 | 7.404M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.217M
Minimum
Sep 2022
75.76M
Maximum
Sep 2023
30.15M
Average
24.24M
Median
Shareholders Equity (Quarterly) Benchmarks
Calidi Biotherapeutics Inc | -10.28M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 351.54M |
Total Liabilities (Quarterly) | 293.92M |
Debt to Equity Ratio | 3.209 |
Current Ratio | 1.548 |
Net Debt Paydown Yield | -0.20% |